NO328846B1 - Bioadhesive sammensetninger og fremgangsmate for fremstilling derav, samt sammensetning for a administrere ett eller flere aktive agens. - Google Patents

Bioadhesive sammensetninger og fremgangsmate for fremstilling derav, samt sammensetning for a administrere ett eller flere aktive agens. Download PDF

Info

Publication number
NO328846B1
NO328846B1 NO20001567A NO20001567A NO328846B1 NO 328846 B1 NO328846 B1 NO 328846B1 NO 20001567 A NO20001567 A NO 20001567A NO 20001567 A NO20001567 A NO 20001567A NO 328846 B1 NO328846 B1 NO 328846B1
Authority
NO
Norway
Prior art keywords
composition
weight
gum
agents
layer
Prior art date
Application number
NO20001567A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001567D0 (no
NO20001567L (no
Inventor
Juan A Mantelle
David Houze
David P Kanios
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22033995&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO328846(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of NO20001567D0 publication Critical patent/NO20001567D0/no
Publication of NO20001567L publication Critical patent/NO20001567L/no
Publication of NO328846B1 publication Critical patent/NO328846B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO20001567A 1997-09-26 2000-03-24 Bioadhesive sammensetninger og fremgangsmate for fremstilling derav, samt sammensetning for a administrere ett eller flere aktive agens. NO328846B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6115597P 1997-09-26 1997-09-26
PCT/US1998/020091 WO1999015210A2 (en) 1997-09-26 1998-09-25 Bioadhesive compositions and methods for topical administration of active agents

Publications (3)

Publication Number Publication Date
NO20001567D0 NO20001567D0 (no) 2000-03-24
NO20001567L NO20001567L (no) 2000-05-25
NO328846B1 true NO328846B1 (no) 2010-05-31

Family

ID=22033995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001567A NO328846B1 (no) 1997-09-26 2000-03-24 Bioadhesive sammensetninger og fremgangsmate for fremstilling derav, samt sammensetning for a administrere ett eller flere aktive agens.

Country Status (14)

Country Link
US (1) US6562363B1 (cs)
EP (1) EP1021204B1 (cs)
JP (1) JP2001517493A (cs)
AT (1) ATE314092T1 (cs)
AU (1) AU750809B2 (cs)
CA (1) CA2304958C (cs)
DE (1) DE69833000T2 (cs)
DK (1) DK1021204T3 (cs)
ES (1) ES2252865T3 (cs)
IL (1) IL135258A0 (cs)
NO (1) NO328846B1 (cs)
NZ (1) NZ504108A (cs)
RU (1) RU2234337C2 (cs)
WO (1) WO1999015210A2 (cs)

Families Citing this family (276)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
EP0965278A1 (en) * 1998-06-16 1999-12-22 Mathias Christian Zohoungbogbo Dietetic food composition and dietetic method using such composition
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
JP2002521324A (ja) * 1998-07-24 2002-07-16 アルザ コーポレイション フェノルドパムの経皮投与のための配合物
CN1331586A (zh) 1998-12-18 2002-01-16 阿尔扎有限公司 透明的透皮烟碱输送装置
PT1061900E (pt) * 1999-01-14 2005-04-29 Noven Pharma Composicoes e metodos para libertacao de uma droga
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
AU2573800A (en) * 1999-02-19 2000-09-04 Takeda Chemical Industries Ltd. Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
PT1183014E (pt) 1999-06-14 2003-12-31 Cosmo Spa Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
WO2001047559A1 (fr) * 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
KR100338327B1 (ko) * 2000-05-16 2002-08-07 주식회사 태평양 피부 외용제 내의 활성성분의 피부 흡수를 증진시킬 수있는 조성물
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
AU2001279934A1 (en) * 2000-08-01 2002-02-13 Sanofi-Synthelabo Pharmaceutical composition for transdermal delivery of befloxatone
EP1334724A4 (en) * 2000-10-16 2007-05-02 Hisamitsu Pharmaceutical Co COMPOSITIONS FOR TOPICAL PREPARATIONS
AU2002214364B2 (en) * 2000-11-06 2004-08-19 Samyang Biopharmaceuticals Corporation Transdermal drug delivery system with improved water absorbability and adhesion properties
US20030045539A1 (en) * 2000-11-06 2003-03-06 Baltazar Gomez-Mancilla Cabergoline and pramipexole: new uses and combinations
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7713472B2 (en) * 2001-01-12 2010-05-11 Board Of Regents, The University Of Texas System Antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
DE60239528D1 (de) * 2001-05-01 2011-05-05 Corium International Redwood City Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8728445B2 (en) * 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050215727A1 (en) * 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
WO2002094179A2 (en) * 2001-05-23 2002-11-28 J.B. Chemicals & Pharmaceuticals Ltd. Novel topical microbicidal compositions
EP1262172A1 (en) * 2001-05-25 2002-12-04 Italmed S.N.C. Di Galli G. & Pacini G. Liquid polymer composition for prevention and treatment of the oral cavity diseases
ATE464887T1 (de) * 2001-05-31 2010-05-15 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
JP4943597B2 (ja) * 2001-07-31 2012-05-30 川澄化学工業株式会社 抗血栓性医療用具
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
CN100411618C (zh) * 2002-05-17 2008-08-20 迪欧加药品公司 有效的选择性阿片受体调制剂化合物的用途
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
WO2004018741A1 (en) * 2002-08-23 2004-03-04 University Of Maryland Biotechnology Institute Assembly of chitosan onto an electrode surface
US20050100515A1 (en) * 2002-09-11 2005-05-12 The Procter & Gamble Company Tooth whitening products
US7138373B2 (en) * 2002-09-26 2006-11-21 University Of Maryland, Baltimore County Polysaccharide-based polymers and methods of making the same
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
ITMI20022271A1 (it) * 2002-10-25 2004-04-26 Farmaka Srl Composizioni farmaceutiche bioadesive a base di anitiinfiammatori non steroidei.
ATE552824T1 (de) * 2002-11-05 2012-04-15 Fadim S R L Kontrollierte und kontinuierliche verabreichung von rifaximin
US8250698B2 (en) * 2002-11-09 2012-08-28 Gavney Jr James A Hybrid cleaning device including absorbent and contact elements
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
US7883615B2 (en) * 2003-02-12 2011-02-08 University Of Maryland, College Park Controlled electrochemical deposition of polysaccharide films and hydrogels, and materials formed therefrom
DE602004025217D1 (cs) * 2003-04-04 2010-03-11 Tissuemed Ltd
CA2523000A1 (en) * 2003-05-07 2004-11-25 Dmi Biosciences, Inc. Oral care methods and products
WO2004112723A2 (en) * 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
WO2005003192A1 (en) * 2003-06-26 2005-01-13 Symyx Technologies, Inc. Synthesis of photoresist polymers
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
ATE415946T1 (de) * 2003-08-08 2008-12-15 Elan Pharma Int Ltd Neue metaxalon-zusammensetzungen
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
US8784874B2 (en) * 2003-09-10 2014-07-22 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
TW200512013A (en) * 2003-09-18 2005-04-01 Orient Europharma Co Ltd Gel formulation of oxybutynin hydrochloride
EP1667645A1 (en) * 2003-09-19 2006-06-14 Symyx Technologies Materials for enhanced delivery of hydrophilic active agents in personal care formulations
JP2007509951A (ja) * 2003-10-28 2007-04-19 ノーヴェン ファーマシューティカルズ インコーポレイテッド 経皮的なドラッグデリバリーシステムにおける医薬品の損失及び送達を制御するための組成物及び方法
DE10352602A1 (de) * 2003-11-11 2005-06-02 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat
US20100330143A1 (en) 2003-12-04 2010-12-30 University Of Utah Research Foundation Modified macromolecules and methods of making and using thereof
WO2005056608A1 (en) 2003-12-04 2005-06-23 University Of Utah Research Foundation Modified macromolecules and methods of making and using thereof
US7375404B2 (en) * 2003-12-05 2008-05-20 University Of Maryland Biotechnology Institute Fabrication and integration of polymeric bioMEMS
US20050132466A1 (en) * 2003-12-11 2005-06-23 Kimberly-Clark Worldwide, Inc. Elastomeric glove coating
US20050127552A1 (en) 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Method for forming an elastomeric article
FR2863502B1 (fr) * 2003-12-15 2007-03-16 Cousin Biotech Implant textile adhesif de refection parietale
SI1548845T1 (sl) * 2003-12-22 2007-06-30 Scheuten Glasgroep Bv postopek za obdelavo prašnih zrn
CA2552911A1 (en) * 2004-01-20 2005-08-11 Board Of Regents, The University Of Texas System Methods for coating and impregnating medical devices with antiseptic compositions
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
IL160936A0 (en) * 2004-02-05 2004-08-31 Scott A Cordray Nasal spray and wash
US20080003248A1 (en) * 2004-03-03 2008-01-03 Constantine Georgiades Whitening products
US20050196355A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
US20070269519A1 (en) * 2004-03-03 2007-11-22 Constantine Georgiades Whitening products
US20050196348A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Stabilized peroxide compositions
US20070190125A1 (en) * 2004-03-03 2007-08-16 Constantine Georgiades Positioning feature for aiding use of film or strip product
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
AU2005244214B2 (en) * 2004-04-29 2010-02-18 Teikoku Pharma Usa, Inc. Topical methadone compositions and methods for using the same
US20070189978A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for dermally treating musculoskeletal pain
US20070196293A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for treating photo damaged skin
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070189980A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for treating alopecia
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US8158139B2 (en) * 2004-07-12 2012-04-17 Taro Pharmaceuticals North America, Inc. Topical gel formulation comprising organophosphate insecticide and preparation thereof
WO2006017263A1 (en) * 2004-07-12 2006-02-16 Taro Pharmaceutical Industries Ltd. Topical gel formulation comprising organophosphate insecticide and its preparation thereof
GB0416861D0 (en) * 2004-07-29 2004-09-01 Quadrant Drug Delivery Ltd Composition
MX2007001384A (es) 2004-08-02 2007-04-19 Glaxo Group Ltd Novedosa composicion para xerostomia.
RU2396985C2 (ru) * 2004-08-03 2010-08-20 Тиссьюмед Лимитед Материалы, обладающие адгезией к тканям
CN103497713B (zh) * 2004-08-05 2018-07-17 考里安国际公司 粘合剂组合物
KR20070072867A (ko) * 2004-09-01 2007-07-06 넥스메드 홀딩스 인코포레이티드 경피성 항구토 전달 시스템, 이의 방법 및 조성물
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
WO2006041907A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
TW200616589A (en) * 2004-10-08 2006-06-01 Noven Pharma Transdermal delivery of drugs based on crystal size
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
EP1923059A1 (en) * 2004-11-04 2008-05-21 BIOFARMITALIA S.p.A. Patch containing a substance selected from tars having reducing characteristics in dermatology
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7582330B2 (en) * 2004-11-24 2009-09-01 3M Innovative Properties Counsel Method for making metallic nanostructures
US20060110540A1 (en) * 2004-11-24 2006-05-25 3M Innovative Properties Company Method for making nanostructured surfaces
US7687115B2 (en) * 2004-11-24 2010-03-30 3M Innovative Properties Company Method for making nanostructured surfaces
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
CA2590136A1 (en) 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
FR2879931B1 (fr) * 2004-12-24 2007-03-30 Rhodia Chimie Sa Materiau silicone pour la liberation d'une molecule active
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
NZ552862A (en) 2005-03-15 2009-03-31 Animal Ethics Pty Ltd A topical analgesic composition
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
AP2244A (en) * 2005-04-26 2011-06-24 Caldwell Galer Inc Topical methadone compositions and methods for using the same.
US9023382B2 (en) * 2005-06-08 2015-05-05 Basf Corporation Medicament carrier composition and method of forming a film therefrom
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
US7560445B2 (en) 2005-07-06 2009-07-14 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
CA2615710C (en) 2005-07-28 2017-09-12 Color Foundation (Stichting Color) Sensitization of immune system against haptenized melanoma antigens
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
US7718716B2 (en) * 2005-10-14 2010-05-18 3M Innovative Properties Company Chromonic nanoparticles containing bioactive compounds
US7629027B2 (en) 2005-10-14 2009-12-08 3M Innovative Properties Company Method for making chromonic nanoparticles
US8119162B2 (en) 2005-11-10 2012-02-21 Colgate-Palmolive Company Particles that disrupt or impede bacterial adhesion, related compositions and methods
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US7807661B2 (en) * 2005-12-08 2010-10-05 3M Innovative Properties Company Silver ion releasing articles and methods of manufacture
CN101370486B (zh) * 2005-12-09 2012-12-05 北京康倍得医药技术开发有限公司 含有硝酸异山梨酯和比索洛尔的透皮贴剂
WO2007070632A2 (en) 2005-12-13 2007-06-21 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
AU2006326018B2 (en) * 2005-12-14 2013-04-18 Nuvo Research Inc. Compositions and methods for dermally treating pain
CA2747845C (en) * 2005-12-14 2012-10-09 Zars Pharma, Inc. Compositions and methods for dermally treating pain
EP1959930A2 (en) * 2005-12-14 2008-08-27 Zars, Inc. Flux-enabling compositions and methods for dermal delivery of drugs
CN101370453B (zh) * 2005-12-14 2013-12-18 努沃研究公司 用于皮肤输送药物的组合物和方法
US8092710B2 (en) * 2005-12-19 2012-01-10 3M Innovative Properties Company Hierarchical chromonic structures
US7601769B2 (en) * 2005-12-19 2009-10-13 3M Innovative Peroperties Company Multilayered chromonic structures
US7541052B1 (en) * 2005-12-23 2009-06-02 Scott Cordray Hypertonic solutions and method of treatment
US7824732B2 (en) * 2005-12-28 2010-11-02 3M Innovative Properties Company Encapsulated chromonic particles
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US20070258935A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water dispersible films for delivery of active agents to the epidermis
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
MX2008015360A (es) * 2006-06-01 2009-03-06 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para su absorcion en el colon.
KR20090015103A (ko) * 2006-06-01 2009-02-11 쉐링 코포레이션 페닐에프린 펄스 방출 제형 및 약제학적 조성물
BRPI0711871A2 (pt) * 2006-06-01 2011-12-06 Schering Corp composições farmacêuticas para liberação sustentada de fenilefrina
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
US7635415B2 (en) 2006-06-29 2009-12-22 The Clorox Company Regenerable cleaning implement for sanitizing a surface
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) * 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
JP2010508289A (ja) * 2006-10-27 2010-03-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド ケトプロフェン極性誘導体の経皮的送達
US7976951B2 (en) 2006-11-14 2011-07-12 Momentive Performance Materials Inc. Laminate containing an adhesive-forming composition
US7829116B2 (en) 2006-11-14 2010-11-09 Momentive Performance Materials Inc. Adhesive-forming composition and blend of adhesives obtained therefrom
KR101488804B1 (ko) * 2006-12-06 2015-02-04 니프로 패치 가부시키가이샤 외용 의약 조성물 및 첩부제
RU2451527C2 (ru) * 2006-12-22 2012-05-27 Лаборатуар Медидом С.А. Система in-situ для внутриартикулярной регенерации хрящевой и костной тканей
CN101677997B (zh) 2007-03-30 2012-05-09 泰奥加制药公司 用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
US20080300322A1 (en) * 2007-06-01 2008-12-04 Atlantic Pharmaceuticals, Inc. Delivery vehicles containing rosin resins
BRPI0812784A2 (pt) * 2007-06-01 2014-12-02 Schering Plough Healthcare Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
ES2729925T3 (es) 2007-11-13 2019-11-07 Meritage Pharma Inc Composiciones de corticosteroides
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US20090221615A1 (en) * 2008-02-29 2009-09-03 Guru Reddy Combination anti-cancer agents
US20110086070A1 (en) * 2008-03-24 2011-04-14 Munish Talwar Orally disintegrating compositions of rhein or diacerein
US9072727B2 (en) * 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
CA2721927C (en) 2008-04-21 2014-01-28 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
WO2009132208A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
EP3560496A1 (en) * 2008-04-29 2019-10-30 Pharnext Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
CN102056578A (zh) * 2008-06-23 2011-05-11 生物递送科学国际公司 多向粘膜给药装置及使用方法
RU2521291C2 (ru) * 2008-06-25 2014-06-27 Эндо Фармасьютикалз Солюшнз Инк. Имплантат октреотида, содержащий высвобождающее вещество
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
US10092580B2 (en) 2008-07-21 2018-10-09 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
KR20110043661A (ko) * 2008-08-12 2011-04-27 노바베이 파마슈티칼즈, 인코포레이티드 항미생물 젤 제형물
LT2328553T (lt) 2008-08-20 2020-09-10 The Regents Of The University Of California Kortikosteroidai, skirti virškinimo trakto uždegiminių ligų gydymui
CA2735418A1 (en) * 2008-08-26 2010-03-11 Ray L. Hauser Substance delivery to skin and other tissues
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
WO2010083035A2 (en) * 2009-01-14 2010-07-22 Corium International, Inc. Transdermal administration of tamsulosin
WO2010088697A2 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Antimicrobial accessory for an implantable medical device
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US8920392B2 (en) 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
US20090318568A1 (en) * 2009-08-26 2009-12-24 Hauser Ray L Adherent coating for tissue surface and/or trans-tissue surface substance delivery
EP2485713B1 (en) * 2009-10-05 2018-09-26 Yissum Research Development Company of the Hebrew University of Jerusalem Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
KR101876693B1 (ko) 2010-03-08 2018-07-09 스펙트럼 파마슈티컬즈 인크 암을 치료하기 위한 티옥산톤계 자가포식작용 저해제 치료제
WO2011117740A2 (en) 2010-03-26 2011-09-29 Philip Morris Products S.A. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
US9572773B2 (en) * 2010-04-26 2017-02-21 Novartis A.G. Layered drug delivery device
MY153762A (en) 2010-04-30 2015-03-13 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
US9579269B2 (en) * 2010-06-23 2017-02-28 Colgate-Palmolive Company Therapeutic oral composition
US8287901B2 (en) * 2010-08-11 2012-10-16 Adhezion Biomedical, Llc Wound healing compositions based on cyanoacrylates and 5,5-disubstitutedhydantoins, including phenytoin
CA2817982C (en) 2010-11-15 2020-06-30 The Regents Of The University Of Michigan Controlled release mucoadhesive systems
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
WO2012122163A1 (en) * 2011-03-07 2012-09-13 3M Innovative Properties Company Microneedle devices and methods
WO2012129429A2 (en) 2011-03-24 2012-09-27 Teikoku Pharma Usa, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
BR112013028802B1 (pt) 2011-05-10 2021-10-26 Itochu Chemical Frontier Corporation Curativo adesivo não-aquoso
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
JP5512891B2 (ja) * 2011-06-20 2014-06-04 久光製薬株式会社 リドカイン含有パップ剤
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
BR112014003651B1 (pt) 2011-08-18 2022-03-29 Biodelivery Sciences International, Inc Dispositivos mucoadesivos resistentes ao mau uso para a liberação de buprenorfina
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
LT2823815T (lt) 2011-09-27 2018-08-27 Itochu Chemical Frontier Corporation Nevandeninis pleistras
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
EP2594132A1 (de) * 2011-11-16 2013-05-22 Lanxess Deutschland GmbH Stabilisierung von Iod enthaltenden Verbindungen mit Stickstoff enthaltenden Polymeren
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9789061B2 (en) * 2012-02-19 2017-10-17 Orahealth Corp. Acacia gum adhesive with calcium carbonate for oral adhering discs
RU2492873C1 (ru) * 2012-10-19 2013-09-20 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Сорбционный материал для лечения ран и ожогов различной этиологии
RU2493877C1 (ru) * 2012-10-19 2013-09-27 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Ранозаживляющее медицинское средство для лечения ран и ожогов с терапевтическим эффектом
BR112015007872A2 (pt) 2012-11-02 2017-07-04 Teikoku Pharma Usa Inc composições transdermais de propinilaminoindano
EP2968652B1 (en) 2013-03-13 2020-07-22 Avery Dennison Corporation Improving adhesive properties
CA2904703A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
WO2014159582A1 (en) * 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
CN105764494A (zh) 2013-10-07 2016-07-13 帝国制药美国公司 右旋美托咪啶经皮递送装置及其使用方法
WO2015054059A2 (en) 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
EP3054930B1 (en) * 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
RU2550916C1 (ru) * 2013-12-26 2015-05-20 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция для лечения заболеваний опорно-двигательного аппарата
FR3017533B1 (fr) * 2014-02-19 2016-03-11 Cousin Biotech Dispositif implantable, notamment pour la refection de paroi abdominale
RU2592370C9 (ru) * 2014-04-24 2016-08-27 Иван Иванович Дедов Средство на основе дегидроэпиандростерона, способ его применения
RU2560516C1 (ru) * 2014-07-21 2015-08-20 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений имени К.И. Скрябина" (ФГБНУ "ВНИИП им. К.И. Скрябина) Антигельминтное средство с трематодоцидной и цестодоцидной активностью
EP3223808B1 (en) 2014-11-25 2019-01-09 Trophea Development AB Treatment of skin atrophy with a combination of triiodothyroacetic acid (triac) and dehydroepiandrosterone (dhea)
CA2993645A1 (en) 2015-07-28 2017-02-02 Otonomy, Inc. Trkb or trkc agonist compositions and methods for the treatment of otic conditions
EP3346998A4 (en) 2015-08-17 2019-08-28 Sidmak Laboratories (India) PVT. Ltd. TOPIC FILM DELIVERY SYSTEM
RU2677338C2 (ru) * 2015-10-06 2019-01-16 Общество с ограниченной ответственностью "Трейдсервис" Лекарственная форма диоксотетрагидрокситетрагидронафталина
CA3029281A1 (en) 2016-06-29 2018-01-04 Otonomy, Inc. Triglyceride otic formulations and uses thereof
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR20180036580A (ko) * 2016-09-30 2018-04-09 주식회사 유스바이오팜 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물
DE102017104026A1 (de) 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
CN110891563B (zh) 2017-08-01 2022-09-02 久光制药株式会社 贴剂
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
US20190192662A1 (en) 2017-12-22 2019-06-27 Noven Pharmaceuticals, Inc. Transdermal pharmaceutical compositions with reduced skin irritation
JP7497289B2 (ja) 2018-01-09 2024-06-10 ドンペ ファーマシューティシ エス．ピー．エー． 成長因子耳用製剤
WO2019154895A1 (en) 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss
AU2019261403A1 (en) * 2018-04-25 2020-11-12 Shinkei Therapeutics, Inc. Tetrabenazine transdermal delivery device
WO2020100096A1 (en) * 2018-11-15 2020-05-22 Glenmark Specialty S.A. Topical composition comprising mupirocin
ES2777899A1 (es) * 2019-02-06 2020-08-06 Hector Alfredo Duilio Polizzi Apósito oral con efecto anestésico
RU2770045C2 (ru) * 2020-04-16 2022-04-14 Андрей Анатольевич Сланевский Способ регенерации резины
CN111671737B (zh) * 2020-05-26 2022-07-08 浙江工业大学 一种地塞米松口腔速溶膜剂及其制备方法
WO2022125405A1 (en) 2020-12-07 2022-06-16 O&M Halyard, Inc. Damp hand donning and moisturizing glove
RU2761303C1 (ru) * 2021-03-15 2021-12-07 Общество с ограниченной ответственностью "Дубна-Биофарм". Способ получения фармацевтической композиции и фармацевтическая композиция для лечения и профилактики заболеваний пародонта
CN113181418B (zh) * 2021-04-09 2022-05-03 青岛大学附属医院 一种医用粘合剂及其制备方法
WO2023062201A1 (en) * 2021-10-15 2023-04-20 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of tizanidine
AU2023232910A1 (en) * 2022-03-11 2024-09-12 Lts Lohmann Therapie-Systeme Ag Transmucosal therapeutic system containing a macrolide immunosuppressant
CA3241999A1 (en) * 2022-03-11 2023-09-14 Marlene Fuhrmann Oromucosal therapeutic system containing an adhesive layer

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050070A (cs) * 1900-01-01
SE352239B (cs) 1966-11-30 1972-12-27 Astra Pharma Prod
GB1430515A (en) 1973-09-04 1976-03-31 Hollister Inc Pharmaceutical preparations
GB2046773B (en) * 1979-03-21 1983-08-03 Advance Tapes Uk Ltd Gelatinous articles and compositions
DE2951319C2 (de) 1979-12-20 1983-12-22 Beiersdorf Ag, 2000 Hamburg Paste für medizinische Zwecke
JPS58213709A (ja) * 1982-06-05 1983-12-12 Teikoku Seiyaku Kk 歯肉粘膜用貼付剤
FR2532546B1 (fr) 1982-09-07 1985-12-27 Biotrol Sa Lab Pate pour la protection de la peau
US4740365A (en) * 1984-04-09 1988-04-26 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
US4755396A (en) 1984-12-10 1988-07-05 Geisler Thomas C Image receiving element for thermal printers
US4751087A (en) 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
USRE33093E (en) 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPH0794384B2 (ja) 1986-09-01 1995-10-11 帝国製薬株式会社 徐放性口腔内用製剤
JPS63160661A (ja) 1986-12-24 1988-07-04 テルモ株式会社 外用組成物
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5032207A (en) 1988-03-04 1991-07-16 Noven Pharmaceuticals, Inc. One-step method for forming a pressure-sensitive adhesive transdermal drug device
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
CA2169729C (en) * 1993-08-19 2001-04-03 James E. Biegajski Water-soluble pressure-sensitive mucoadhesive
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity

Also Published As

Publication number Publication date
ATE314092T1 (de) 2006-01-15
AU9581398A (en) 1999-04-12
ES2252865T3 (es) 2006-05-16
EP1021204A2 (en) 2000-07-26
CA2304958C (en) 2008-12-30
RU2234337C2 (ru) 2004-08-20
NO20001567D0 (no) 2000-03-24
US6562363B1 (en) 2003-05-13
WO1999015210A2 (en) 1999-04-01
NO20001567L (no) 2000-05-25
WO1999015210A3 (en) 1999-06-17
WO1999015210B1 (en) 1999-08-19
CA2304958A1 (en) 1999-04-01
EP1021204B1 (en) 2005-12-28
DK1021204T3 (da) 2006-05-08
DE69833000D1 (de) 2006-02-02
JP2001517493A (ja) 2001-10-09
IL135258A0 (en) 2001-05-20
AU750809B2 (en) 2002-07-25
DE69833000T2 (de) 2006-09-07
NZ504108A (en) 2002-06-28

Similar Documents

Publication Publication Date Title
DE69833000T2 (de) Bio-klebemittelzusammensetzungen
US10231938B2 (en) Transdermal drug delivery device including an occlusive backing
US5446070A (en) Compositions and methods for topical administration of pharmaceutically active agents
US5719197A (en) Compositions and methods for topical administration of pharmaceutically active agents
US6638528B1 (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
US6221383B1 (en) Solubility parameter based drug delivery system and method for altering drug saturation concentration
US20040018241A1 (en) Bioadhesive compositions and methods for topical administration of active agents
US7026360B1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
WO2001039749A2 (en) Fast dissolving composition with prolonged sweet taste
TW541183B (en) Bioadhesive compositions and methods for topical administration of active agents
MXPA00002983A (en) Bioadhesive compositions and methods for topical administration of active agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees